The latest acquisition of $3.5 million in research funds from the National Institutes of Health will support investigation in several fields and create up to 26 jobs within the recovery time frame that extends through September 2010.
"These dollars not only will create lots of high-level new jobs, but will advance our work in the prevention, diagnosis and treatment of major diseases," said Tom Rosenquist, Ph.D., vice chancellor for research. "We are grateful to Sen. Ben Nelson and the Congress for the opportunity to compete for these funds."
Award recipients and their studies include:
- Oluwatoyin Asojo, Ph.D. -- $54,000 to study the mechanism of cancer drug transport and resistance.
- Pamela Carmines, Ph.D. -- $98,780 to study new therapeutic strategies to improve renal function in renal and cardiovascular diseases.
- Carol Casey, Ph.D. -- $499,999 to identify therapeutic strategies to reduce the severity and progression of alcoholic liver disease.
- Wing Chan, M.D. -- $369,275 to perform gene expression profiling to study uncommon tumors.
- Maurice Godfrey, Ph.D. -- $100,000 to expand science education activities for teachers and students on American Indian reservations.
- Karen Gould, Ph.D. -- $108,000 to determine how a drug used to treat breast cancer promotes colon cancer.
- Keith Johnson, Ph.D. -- $400,000 to support two collaborative projects related to oral health.
- Jennifer Larsen, M.D. -- $99,955 to determine nontraditional risk factors for heart disease after kidney transplantation.
- Robert Norgren, Ph.D. -- $538,868 for gene sequencing in areas such as neuroscience, developmental disorders and HIV/AIDS.
- Steven Sansom, Ph.D. -- $90,000 to discover better ways to manage blood pressure and sodium content in the elderly.
- Joyce Solheim, Ph.D. -- $89,605 to better understand how cells alert the immune system if they are cancerous or infected with viruses.
- Wallace Thoreson, Ph.D. -- $90,082 to examine the movements of single molecules in the onset of blindness.
- Kay-Uwe Wagner, Ph.D. -- $197,273 to determine how altered gene expression affects the onset and progression of breast cancer.
UNMC also received $556,414 to hire newly-independent investigators for research into chronic heart failure and the Eppley Cancer Center received $242,673 to improve the efficiency and effectiveness of clinical trials.